Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial

Fischer, Kirsten; Bahlo, Jasmin; Maria Fink, Anna; Goede, Valentin; Herling, Carmen; Cramer, Paula; Langerbeins, Petra; von Tresckow, Julia; Engelke, Anja; Maurer, Christian; Kovács, Gábor; Herling, Marco; Tausch, Eugen; Kreuzer, Karl-Anton; Eichhorst, Barbara; Böttcher, Sebastian; F. Seymour, John; Ghia, Paolo; Marlton, Paula; Kneba, Michael; Wendtner, Clemens‐Martin; Döhner, Hartmut; Stilgenbauer, Stephan; Hallek, Michael

doi:10.1182/blood-2015-06-651125

Public

Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial

Published in Blood • Oct 20, 2015

Authors:

Kirsten Fischer

Jasmin Bahlo

Anna Maria Fink

Abstract

Despite promising results with targeted drugs, chemoimmunotherapy with fludarabine, cyclophosphamide (FC), and rituximab (R) remains the standard therapy for fit patients with untreated chronic lymphocytic leukemia (CLL). Herein, we present the long-term follow-up of the randomized CLL8 trial report...

Subject

Chemoimmunotherapy

Medicine

Internal medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!